title: [Extracorporeal therapy of rheumatoid arthritis].
authors.forename: E A
authors.initials: EA
authors.lastname: Aseeva
authors.forename: S K
authors.initials: SK
authors.lastname: Solov'ev
authors.forename: A S
authors.initials: AS
authors.lastname: Chiklikchi
mesh_terms: D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000627:therapeutic use; D018501:Antirheumatic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000097:blood / Q000188:drug therapy / Q000276:immunology / Q000628:therapy*; D001781:Blood Component Removal; D003131:Combined Modality Therapy; D018849:Controlled Clinical Trials as Topic; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000627:therapeutic use; D016238:Cytapheresis; D004311:Double-Blind Method; D005938:Glucocorticoids / Q000008:administration & dosage / Q000627:therapeutic use; D006440:Hemofiltration; D006801:Humans; D007163:Immunosorbent Techniques; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000627:therapeutic use; D007937:Leukapheresis; D008727:Methotrexate / Q000008:administration & dosage / Q000627:therapeutic use; D008775:Methylprednisolone / Q000008:administration & dosage / Q000627:therapeutic use; D010956:Plasmapheresis; D013997:Time Factors
chemical_list: D000893:Anti-Inflammatory Agents; D018501:Antirheumatic Agents; D005938:Glucocorticoids; D007166:Immunosuppressive Agents; D003520:Cyclophosphamide; D008775:Methylprednisolone; D008727:Methotrexate
vernacular_title: Ekstrakorporal'naia terapiia revmatoidnogo artrita.